NCT07207122View on ClinicalTrials.gov

Effects of Transcranial Ultrasound Stimulation (TUS) on Neurological and Cognitive Outcomes in Neurodegenerative Diseases

NARecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 8, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

August 31, 2026

Conditions
Parkinson DiseaseParkinson's Disease (PD)Parkinson's Disease Dementia (PDD)Parkinson's Disease DementiaAlzheimer'sAlzheimer's Disease (AD)Mild Cognitive Impairment
Interventions
DEVICE

Transcranial focused ultrasound modulation administered to a region involved in disease pathology.

Using Sanmai's device to administer tFUS to regions of interest.

Trial Locations (1)

90403

RECRUITING

The Regenesis Project, Santa Monica

Sponsors

Collaborators (1)

Acacia Research
All Listed Sponsors
collaborator

Acacia Research

UNKNOWN

collaborator

University of New Mexico

OTHER

collaborator

BrainMind

UNKNOWN

collaborator

The Regenesis Project

UNKNOWN

lead

Sanmai Technologies PBC dba Sanmai

INDUSTRY

NCT07207122 - Effects of Transcranial Ultrasound Stimulation (TUS) on Neurological and Cognitive Outcomes in Neurodegenerative Diseases | Biotech Hunter | Biotech Hunter